Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDT + Bevacizumab vs PDT + Bevacizumab + Triamcinolone in Neovascular AMD
NCT00370539Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in neovascular age-related macular degeneration (NVAMD), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT00370539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370539.